ROI-21-0694 Valoa Technologies Inc.: Non-Invasive Substance Concentration Measurement - 3 assets

3 US issued patents, 1 US application (expired) and 4 International counterparts (EP, JP) related to biomedical testing to monitor glucose measurements.

Broker listed companies and products of potential interest: Omron - Blood Glucose Monitoring System HGM-111, Medtronic - Continuous Glucose Monitoring, Orsense - NBM 200 system, ADInstruments - Oximeter Pods, DiaMonTech AG - DiaMonTech, Abbott, General Electric (GE), Medtronic, Koninklijke Philips N.V., and many more. 

Package data provided by Richardson Oliver Insights.

Contact info: Justin Ehrlickman, +1 (845)-558-7901, justin@ipapproach.com

Transactions: 

Company details

Send message

Please register to send messages.